
The European Commission has granted marketing authorisation for Shire’s Intuniv for the treatment of ADHD in children. Intuniv (guanfacine hydrochloride prolonged …

Shire has posted strong growth in its full-year results, showing that the company is faring well even after the collapse …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

